MedPath
HSA Approval

CHEMCADE POWDER FOR SOLUTION FOR INJECTION 3.5 MG / VIAL

SIN17219P

CHEMCADE POWDER FOR SOLUTION FOR INJECTION 3.5 MG / VIAL

CHEMCADE POWDER FOR SOLUTION FOR INJECTION 3.5 MG / VIAL

April 15, 2025

CHEMKRAFT PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantCHEMKRAFT PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

INJECTION, POWDER, FOR SOLUTION

INTRAVENOUS, SUBCUTANEOUS

Medical Information

L01XG01

Manufacturer Information

CHEMKRAFT PTE. LTD.

SIA PHARMIDEA

Active Ingredients

Bortezomib (as a mannitol boronic ester)

3.5 mg / vial

Bortezomib

Documents

Package Inserts

CHEMCADE Injection PI.pdf

Approved: April 15, 2025

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

CHEMCADE POWDER FOR SOLUTION FOR INJECTION 3.5 MG / VIAL - HSA Approval | MedPath